How NHS Scotland will not be ‘decimated’ by private equity because the SNP oversight ‘of devolved, generous funding enables a “collectivist” approach with less private penetration.’

Policy Resistance: Scotland’s integrated system (14 regional boards, no trusts) emphasizes collaboration over competition, rejecting England’s market-based reforms. Private practice is “much less common,” and outsourcing is rare—limited to overflow cases (e.g., ~0.5% of operations in 2021, or ~1,500 procedures annually). The Scottish Government prioritizes prevention and equity, with frameworks like the 2025 Population Health Framework focusing on social determinants rather than PPPs. Limited PE Activity: No major PE deals specific to NHS Scotland in 2025 searches. General Scottish PE interest rose 35.6% in 2024, but healthcare remains niche. Legacy PFI/non-profit distributing (NPD) contracts exist (e.g., expiring in 2025), but successors avoid heavy private involvement. Funding is ~20–25% higher per head than England (£12 billion in 2024/25), supporting public capacity without privatization incentives. Performance Edge: Scotland maintains better metrics (e.g., fewer long A&E waits, higher doctor/nurse ratios), shielding it from England’s backlog-driven PE reliance. Cross-border care adds complexity, but devolution enables resistance to Westminster trends.

How NHS Scotland will not be ‘decimated’ by private equity because the SNP oversight ‘of devolved, generous funding enables a “collectivist” approach with less private penetration.’

Guess You Like